LTFS
VRCA icon

Ladenburg Thalmann Financial Services’s Verrica Pharmaceuticals VRCA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
12
– – ﹤0.01% 5115
2019
Q3 		$2K Hold
12
– – ﹤0.01% 5007
2019
Q2 		$1K Hold
12
– – ﹤0.01% 5164
2019
Q1 		$1K Hold
12
– – ﹤0.01% 5120
2018
Q4 		$1K Buy
+12
New +$1.46K ﹤0.01% 5096

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VRCA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Verrica Pharmaceuticals (VRCA) position steady in Q4 2019 at 12 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5115.

Ladenburg Thalmann Financial Services first reported a position in VRCA in Q4 2018 and has held it in 5 quarters since. 52 funds tracked by Wall St. Rank hold VRCA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 12 shares of Verrica Pharmaceuticals worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Verrica Pharmaceuticals share count unchanged in Q4 2019.
  • Verrica Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5115 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Verrica Pharmaceuticals in Q4 2018 and has held it in 5 quarters since.
  • 52 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.